Neoadjuvant sintilimab and chemotherapy in patients with resectable esophageal squamous cell carcinoma: A prospective, single-arm, phase 2 trial.
Frontiers in immunology(2022)
Abstract
http://www.chictr.org.cn/, ChiCTR1900026593.
MoreTranslated text
Key words
esophageal squamous cell carcinoma,neoadjuvant,prospective,resectable,sintilimab and chemotherapy
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined